Status:
RECRUITING
Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms
Lead Sponsor:
Yuanjiao Yan
Conditions:
Cognitive Dysfunction
Eligibility:
All Genders
60+ years
Brief Summary
The goal of this clinical trial is aims to: 1. Translate and culturally adapt the Cognitive Leisure Activity Scale (CLAS) into Chinese and Conduct reliability and validity tests for the Chinese versi...
Detailed Description
Alzheimer's disease (AD), also known as senile dementia, is the most common neurodegenerative disorder characterized by progressive decline in cognitive function and behavioral impairment. It is estim...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Mild Cognitive Impairment (MCI) and Subjective Cognitive Decline (SCD)
- Age ≥ 60 years
- Capable of normal communication in Mandarin，possesses a certain level of comprehension and judgment.
Exclusion
- Individuals with severe hearing or language impairments, or with severe physical illnesses that are unable to cooperate with the survey
- Individuals with pacemakers, metallic implants, cochlear implants, claustrophobia, and other contraindications for MRI examination.
Key Trial Info
Start Date :
April 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT06215274
Start Date
April 27 2024
End Date
December 31 2026
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Provincial Hospital
Fuzhou, Fujian, China, 350001